TRV
TRAVELERS COMPANIES, INC.
Next earnings Jul 17, 2026 (before open) · consensus $4.88 EPS, $11.4B rev
Last earnings -0.2% on 2026-04-16
$342.31
▲ +3.14%$342.31▲ +32.07%
over 1Y
L $246.70H $342.31
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.1%
1W+7.5%
1M+17.8%
3M+16.9%
YTD+21.0%
1Y+32.1%
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 33 analysts
Hold
Quality P&C insurer at 11x earnings with 19% ROE and EPS +28% — cheap for a compounder buying back stock; cat risk is the catch.
P/E (price / FY diluted EPS) 11.2 · FY2025
The read
Quality fundamentals and an attractive price line up (~180% below fair value) — the rarer case where both the business and the entry look good.
Travelers is a high-quality property-casualty franchise being priced like a no-growth cyclical. Revenue has climbed steadily from $34.8B (FY2021) to $48.8B (FY2025, +5.2% YoY), and net income has recovered from the catastrophe-pressured $2.84B trough in FY2022 to $6.29B (+25.8%), driving diluted EPS up 27.8% to $27.43. ROE of 19.1% and operating cash flow of $10.6B (+16.9%) confirm the earnings are real and cash-backed, not accounting artifacts. Stockholders' equity rose 18.1% to $32.9B, helped by retained earnings of $54.9B and a recovery in the bond portfolio's mark.
At $307.81 the stock trades at 11.2x FY2025 EPS and 1.4x sales — a discount valuation for a business earning a ~19% return on equity and growing EPS near 28%. Part of that EPS growth is mechanical and durable: the share count fell 4.6% as buybacks tripled to $3.0B (+199.5%), and the company paid another $979M in dividends, all comfortably covered by $10.6B of operating cash flow. Aggressive repurchase at 11x earnings is accretive and signals management's own read on value; it is the single biggest reason EPS (+27.8%) is outrunning net income (+25.8%).
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 18, 2026, 7:22 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $34.8B | $36.9B | $41.4B | $46.4B | $48.8B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $3.66B | $2.84B | $2.99B | $5.00B | $6.29B |
| Diluted EPS | $14.49 | $11.77 | $12.79 | $21.47 | $27.43 |
| Net margin | 10.5% | 7.7% | 7.2% | 10.8% | 12.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)0.48
Earnings yield8.6%
FCF yield—
Quality & risk
ROIC (est.)7.4%
Free cash flow—
Total debt$6.16B
Net cash-$5.32B
Piotroski F-Score6/7
Capital returns
Buyback yield4.1%
Dividend yield (est.)1.3%
Shareholder yield5.5%
Shares Δ YoY-4.6%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRecent disclosure tone has been improving.
- 8-K Officer / director change2026-05-22
Annual meeting: directors elected, say-on-pay and board matters voted
- 8-K Other event2026-05-21
Other-event 8-K: a material corporate update disclosed via exhibit
- 8-K Earnings results2026-04-16
Q1 2026 earnings released vs. the prior-year quarter
- 10-Q Quarterly report2026-04-16
Q1 2026 earnings released vs. the prior-year quarter
- DEF 14A Proxy statement2026-04-07
- 8-K Officer / director change2026-02-17
Board/exec change plus a Reg FD investor disclosure
- 10-K Annual report2026-02-12
- 8-K Officer / director change2026-02-06
Leadership change: an officer/director appointment or departure
- 8-K Earnings results2026-01-21
Q4/FY25 results: net income $6.29B (+26%), diluted EPS $27.43 (+28%)
Recent filings
all on EDGAR ↗4Period ending 2026-06-302026-07-01open ↗4Period ending 2026-06-302026-07-01open ↗11-KPeriod ending 2025-12-312026-06-15open ↗4Period ending 2026-05-262026-05-27open ↗4Period ending 2026-05-222026-05-26open ↗144Filing2026-05-26open ↗8-KPeriod ending 2026-05-202026-05-22open ↗144Filing2026-05-22open ↗8-KPeriod ending 2026-05-152026-05-21open ↗DEFA14AFiling2026-05-12open ↗13F-HRPeriod ending 2026-03-312026-05-11open ↗SCHEDULE 13G/AFiling2026-05-06open ↗
Frequently asked
- Is TRAVELERS COMPANIES, INC. (TRV) a buy?
- TRV currently carries a Buy rating with 4/5 conviction, derived from its latest SEC filings. Quality P&C insurer at 11x earnings with 19% ROE and EPS +28% — cheap for a compounder buying back stock; cat risk is the catch.
- What is TRV's fair value?
- A Modified-Graham model based on TRV's SEC fundamentals estimates a fair value of about $957.22. It is an estimate from reported earnings, not a price target.
- Is TRV overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, TRV currently appears undervalued relative to its SEC-grounded earnings power.
- What is TRAVELERS COMPANIES, INC.'s quality score?
- TRV scores 80.25473866056004/100 (grade A-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0000086312, latest 10-Q filed 2026-04-16) · EODHD · Proprietary analysis · as of 6/18/2026, 11:22:51 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.